| 000 | 00938 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513092412.0 | ||
| 264 | 0 | _c19960819 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0362-5664 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeydoun, A | |
| 245 | 0 | 0 |
_aGabapentin: pharmacokinetics, efficacy, and safety. _h[electronic resource] |
| 260 |
_bClinical neuropharmacology _cDec 1995 |
||
| 300 |
_a469-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcetates _xadverse effects |
| 650 | 0 | 4 | _aAmines |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 | _aCyclohexanecarboxylic Acids |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aGabapentin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _agamma-Aminobutyric Acid |
| 700 | 1 | _aUthman, B M | |
| 700 | 1 | _aSackellares, J C | |
| 773 | 0 |
_tClinical neuropharmacology _gvol. 18 _gno. 6 _gp. 469-81 |
|
| 999 |
_c8679137 _d8679137 |
||